Denk-Air Junior 4mg tablets chewable

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

montelukast (montelukast sodium)

Available from:

Denk Pharma GmbH & Co. KG

ATC code:

R03DC03

INN (International Name):

montelukast (montelukast sodium)

Dosage:

4mg

Pharmaceutical form:

tablets chewable

Units in package:

(28/2x14/) in blister

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2017-06-22

Patient Information leaflet

_Denk-Air Junior 4 mg_
For children 2 to 5 years of age
Chewable tablet – oral use
Leukotriene receptor antagonist
Active substance: montelukast
PACKAGE LEAFLET:
INFORMATION FOR THE USER
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOUR
CHILD STARTS TAKING THIS MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
– Keep this leaflet. You may need to read it
again.
– If you have any further questions, ask your
doctor or pharmacist.
– This medicine has been prescribed for your
child. Do not pass it on to others. It may harm
them, even if their signs of illness are the
same as your child’s.
– If any of the side effects gets serious, talk to
your doctor or pharmacist. This includes any
possible side effects not listed in this leaflet.
See section 4.
WHAT IS IN THIS LEAFLET
1. WHAT DENK-AIR JUNIOR 4 MG IS AND
WHAT IT IS USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU USE
DENK-AIR JUNIOR 4 MG
3. HOW TO USE DENK-AIR JUNIOR 4 MG
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE DENK-AIR JUNIOR 4 MG
6. CONTENTS OF THE PACK AND OTHER INFORMATION
1.
WHAT DENK-AIR JUNIOR 4 MG IS
AND WHAT IT IS USED FOR
Denk-Air Junior 4 mg is a medicine that blocks the
binding of certain inflammatory mediators
(leukotrienes). Leukotrienes cause narrowing and
swelling of the airways in the lungs. By blocking the
leukotrienes, Denk-Air Junior 4 mg alleviates the
symptoms of asthma, and helps to control asthma.
The doctor has prescribed Denk-Air Junior 4 mg for
your child so as to prevent symptoms of asthma
occurring during the day and night.
– Denk-Air Junior 4 mg is used in children 2 to
5 years of age whose asthma symptoms could not
be adequately controlled by previous medication
and who require an additional treatment.
– Denk-Air Junior 4 mg can also be used in children
2 to 5 years of age instead of inhalations contain-
ing cortisone (inhaled corticosteroids), under the
following circumstances:
• if there have been no recent, severe asthma
attacks which have required treatment with
cortisone tablets.
• if the child is unable to